Palmitoyl Pentapeptide-4 is a cosmetic peptide ingredient discussed in anti-aging and skin care formulation contexts. This page helps B2B buyers confirm naming, understand documentation scope, and prepare a more accurate RFQ before comparing suppliers.
Direct Answer
Confirm naming, CAS, document scope, and inquiry intent before sample, MOQ, lead-time, or bulk quotation discussion.
Specifications
Typical Applications
MOQ / Lead Time / Samples
Why buyers trust WUMO
In this market, “99% pure” is often quoted while the amount actually delivered is far less. We keep purity and real content separate, and put both on paper — so Palmitoyl Pentapeptide-4 | B2B Cosmetic Peptide Sourcing, Documentation and RFQ Guide | WUMO is backed by documents you can check.
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
Identity and quality are confirmed by batch documentation — COA, plus HPLC / MS where applicable — before material is released.
Ingredient identity (INCI / CAS), specification sheet and SDS are available for review. Match the documents to your quoted batch before you commit.
Documents Available
COA
Batch-level quality summary for buyer-side file review.
Request this file through the inquiry path below.
SDS / MSDS
Safety document requested for internal purchasing and handling review.
Request this file through the inquiry path below.
HPLC
Purity profile reference for the quoted project or batch where available.
Request this file through the inquiry path below.
LC-MS
Identity confirmation support for documentation review where available.
Request this file through the inquiry path below.
Specification Sheet
Product or packaging specification reference for quotation alignment.
Request this file through the inquiry path below.
Overview
Palmitoyl Pentapeptide-4 is a cosmetic peptide ingredient discussed in anti-aging and skin care formulation contexts. This page helps B2B buyers confirm naming, understand documentation scope, and prepare a more accurate RFQ before comparing suppliers.
Details
Palmitoyl Pentapeptide-4 is a cosmetic peptide ingredient commonly referenced in anti-aging and skin care formulation development. For B2B buyers, the first sourcing task is not usually price comparison. It is confirming that both buyer and supplier are referring to the same material — the same INCI name, the same specification, the same format, and the same documentation scope.
Buyers sourcing this ingredient may encounter it under different names, product references, or supplier designations. They may also find that Palmitoyl Pentapeptide-4 and Palmitoyl Tripeptide-5 appear in similar formulation discussions — but these are different compounds with different sequences, different specifications, and different documentation. The two names are not interchangeable in an RFQ.
This page is intended to help procurement managers, cosmetic ingredient buyers, formulation teams, and distributors confirm naming, understand which documents to request, and prepare a clearer RFQ before requesting or comparing supplier quotations.
Buyers may search for this ingredient under several terms — INCI name, cosmetic peptide category, supplier product reference, or a shorthand from a formulation brief. Before requesting quotation or comparing documents, it is useful to confirm that buyer and supplier are referring to the same material.
| Term or Reference | How Buyers May Encounter It | What Should Be Confirmed Before Quotation |
|---|---|---|
| Palmitoyl Pentapeptide-4 | INCI name used in ingredient listings, formulation specifications, and regulatory labeling documentation | Confirm that the supplier's product is listed and tested under this designation; request specification sheet and COA for verification |
| Palmitoyl Pentapeptide 4 (no hyphen) | Informal reference in formulation briefs, procurement databases, or supplier catalogues | Cross-check against the formal INCI format and supplier documentation before issuing an RFQ |
| Cosmetic peptide ingredient / signal peptide | Category reference used in formulation sourcing discussions | Not specific enough for a quotation; confirm INCI name and CAS reference before proceeding |
| Anti-aging peptide ingredient (formulation context) | Broad category reference that may appear in product development briefs | This context may refer to multiple different compounds; confirm the exact ingredient name before requesting a quotation |
Naming should also be confirmed against the buyer's formulation and regulatory context. INCI designation, labeling requirements, and documentation format may vary depending on the destination market and the product category the formulation falls into. If there is any ambiguity between the formulation specification and the supplier's product reference, resolve this before the RFQ stage.
These two cosmetic peptide ingredients appear in similar product development discussions and are sometimes mentioned in the same anti-aging formulation context. They are not the same compound, and they should not be treated as interchangeable in an RFQ or supplier comparison.
| Item | Palmitoyl Pentapeptide-4 | Palmitoyl Tripeptide-5 | Buyer Note |
|---|---|---|---|
| INCI name | Palmitoyl Pentapeptide-4 | Palmitoyl Tripeptide-5 | Different INCI names; confirm which ingredient the formulation specification calls for before submitting an RFQ |
| Peptide chain length | Pentapeptide — 5 amino acids | Tripeptide — 3 amino acids | Different sequence and molecular weight; confirm against the specification sheet, not by name alone |
| Documentation match | COA, spec sheet, and HPLC should reference Palmitoyl Pentapeptide-4 | Separate documents specific to Palmitoyl Tripeptide-5 | Do not accept documents for one compound as verification for the other |
| Supplier quotation | Quotation should explicitly name the ingredient and reference the corresponding batch COA | Separate quotation; should not be combined with Pentapeptide-4 pricing without explicit supplier confirmation | Confirm the ingredient name on the quotation matches the formulation requirement |
| Formulation context | Referenced in cosmetic anti-aging formulation discussions; confirm with formulation brief | Also referenced in anti-aging formulation contexts; confirm separately with formulation team | The shared category context does not make them substitutable — confirm the exact ingredient before sourcing |
| RFQ approach | Specify INCI name and CAS reference in the RFQ; confirm documentation scope separately | Issue a separate RFQ for Tripeptide-5; do not combine with Pentapeptide-4 inquiries | Separate RFQs reduce the risk of quotation confusion between the two compounds |
These two ingredient names should not be treated as interchangeable in sourcing conversations. Buyers should confirm the exact ingredient, its documentation scope, and the quotation unit before comparing suppliers or submitting a combined RFQ.
Before requesting a formal quotation or evaluating a supplier's price, buyers should work through the following specification review items. For cosmetic ingredient sourcing, the earlier these are clarified, the fewer revision rounds the quotation process requires.
| Review Item | What Buyers Should Check | Why It Matters Before Quotation |
|---|---|---|
| Product name and naming | Does the supplier's product designation match the INCI name and CAS reference the buyer intends to purchase? | Naming discrepancies between buyer and supplier can result in quoting the wrong material |
| Batch COA | Does the COA match the requested product name, batch reference, and specification format? | A COA issued for a different batch or product format does not verify the order being placed |
| Appearance and physical specification | Does the stated appearance match the buyer's formulation and handling requirements? | Confirm by current batch COA; physical specification may vary by batch |
| Purity or assay, where available | What test method is used, and what does the purity figure represent? | Confirm by current batch COA; purity method and threshold should be matched to the buyer's specification requirement |
| HPLC / LC-MS documentation, where available | Is a chromatogram or mass confirmation report available? Was it generated in-house or by an accredited third-party laboratory? | The testing source determines what the document can independently verify |
| SDS | Is the SDS format and language appropriate for the destination market and the buyer's internal handling documentation requirements? | Required for import clearance and handling documentation in most markets |
| Packaging format | Has the format — bulk powder, packaged unit, sample — been confirmed before the quotation was requested? | Packaging format affects MOQ, lead time, and documentation scope |
| MOQ and lead time assumptions | Are the MOQ and lead time figures based on confirmed format, quantity, and documentation scope? | Indicative figures issued without confirmed scope may not reflect the actual order requirements |
For Palmitoyl Pentapeptide-4 sourcing, the following documents are commonly requested in B2B procurement conversations. Document availability may vary by batch, format, and project scope, and should be confirmed before quotation or order placement.
The COA is the baseline reference document for any B2B ingredient order. It should confirm product name, batch identification, purity result (with testing method stated), appearance, and results against specification. For cosmetic ingredient buyers, the COA should clearly reference the correct INCI name and batch number for the material being supplied. A COA issued for a different batch or a different specification is not a substitute for the order being placed.
Required for shipping documentation and import clearance in most markets. Buyers should confirm that the SDS language and format meet the requirements of their destination country and their internal safety documentation standards before order confirmation.
Where available, an HPLC report provides purity and peak profile data from the actual production batch. For buyers using this document in supplier qualification, it is worth confirming whether the result was generated by an in-house instrument or by an accredited third-party laboratory — the source affects what the document can independently support.
Where available, an LC-MS report may support molecular weight confirmation for the peptide. This is a useful step for first orders from a new supplier, or for projects where compound identity is part of the formal evaluation criteria. Clarify the testing source and scope before treating this document as a qualification reference.
Defines the nominal product specification — the target purity, appearance, and parameters the material is expected to meet. A specification sheet describes the product as defined; batch documents confirm what a specific batch actually was. Both serve a role and should not be used interchangeably.
Not every document will be available for every batch or project format. Availability should be confirmed with the supplier before order placement, not assumed after.
Quotations for the same INCI name can vary significantly depending on packaging format, documentation scope, and order stage. A lower unit price does not always mean a lower total cost once packaging, testing, and shipping are considered.
Bulk powder vs. packaged formats Bulk powder sourcing typically carries a lower minimum quantity threshold. Packaged formats — measured units, labeled containers, sample quantities — involve additional handling that raises MOQ and may extend lead time. Buyers comparing bulk and packaged quotations are not comparing equivalent cost structures.
Sample orders vs. commercial batches Sample orders are often handled on different pricing and lead time terms than commercial batches. An indicative price at sample stage may not reflect the per-unit cost at commercial volume. Both are valid reference points, but they are not the same quotation.
Custom packaging and private label Custom label or packaging requirements introduce additional steps — label design approval, packaging material procurement, minimum run quantities — that affect both MOQ and production timeline. These should be discussed at the RFQ stage, not after the order is confirmed.
Documentation scope and lead time An order requiring third-party HPLC confirmation, LC-MS, and destination-country SDS formatting takes more preparation time than a standard COA and SDS package. Documentation scope should be factored into the lead time expectation from the start of the sourcing conversation.
Destination country Import documentation format, cold chain requirements, and customs declaration requirements vary by destination. These affect final cost and preparation time, and are worth establishing before rather than after a quotation is issued.
Final MOQ and lead time depend on the confirmed project scope. Indicative quotations issued without confirmed format, quantity, documentation, and destination should be treated as preliminary.
The following checklist covers the details most useful to include in an initial RFQ. A more complete RFQ produces a more accurate supplier response and reduces the number of follow-up rounds before a usable quotation is received.
Product identification - [ ] Ingredient name: Palmitoyl Pentapeptide-4 (INCI name confirmed against formulation brief) - [ ] CAS number reference, if applicable to the buyer's specification - [ ] Confirm whether the requirement is for bulk peptide or a pre-formulated carrier blend
Format and packaging - [ ] Required format: bulk powder, packaged unit, sample, or private label - [ ] Packaging specification if non-standard (container size, label requirement, outer box format)
Quantity and order stage - [ ] Target quantity - [ ] Sample evaluation stage or commercial batch - [ ] Whether quantity is fixed or adjustable based on MOQ
Documentation required - [ ] COA (confirm required format and fields) - [ ] SDS (confirm language and format for destination country) - [ ] HPLC chromatogram (confirm whether third-party lab report is required) - [ ] LC-MS report (confirm scope and testing source) - [ ] Specification sheet
Logistics and destination - [ ] Destination country and city - [ ] Preferred incoterms - [ ] Import documentation requirements specific to the destination market - [ ] Cold chain or temperature-controlled shipping requirements, if applicable
Timeline - [ ] Required delivery date or acceptable lead time window - [ ] Quotation deadline
Other - [ ] Private label requirement, if any - [ ] Regulatory documentation needed for import or labeling - [ ] Whether this is a first order from WUMO or a repeat sourcing inquiry
In practice, a significant share of sourcing delays in cosmetic peptide ingredient projects arise not from production or shipping, but from the early stages — an RFQ that did not specify packaging format, a quotation that assumed bulk when the buyer needed a packaged unit, or a documentation request that arrived after order placement rather than before it.
WUMO prefers to work through naming, packaging format, documentation scope, and delivery assumptions before issuing a formal quotation. A quotation built on confirmed assumptions is a more useful document — one that can actually be used to make a sourcing decision. A fast price against an unclear specification tends to become a slower process once the gaps surface: the quotation needs revising, the documentation scope needs renegotiating, and the lead time needs recalculating.
For buyers who are still working through specification or packaging details, a pre-quotation conversation is a reasonable starting point. It is not necessary to have a complete RFQ ready before making contact.
For Palmitoyl Pentapeptide-4 sourcing, documentation requests, or RFQ preparation support, WUMO is available for qualified B2B project inquiries.
If specification or packaging details are still being confirmed, a pre-quotation conversation is a practical starting point.
Related reading: Custom Peptide Sourcing and CMO Project Support · Bulk Peptide Purchasing Guide: MOQ, Lead Time, and Cost Considerations · Peptide Documentation Center · Palmitoyl Tripeptide-5: A Practical Guide for B2B Buyers
Related Peptides
Peptide Raw Materials
Cosmetic peptide commonly reviewed for firming-oriented and skin-support formulation projects in serums, creams, masks, and related facial care formats.
Peptide Raw Materials
Cosmetic peptide commonly reviewed for soothing-oriented and skin-comfort formulation projects in serums, creams, masks, and related facial care formats.
Peptide Raw Materials
Cosmetic peptide commonly reviewed for premium skin-care, skin-comfort, and multi-functional facial care formulation projects in serums, creams, masks, and related product formats.
FAQ
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.